<SEC-DOCUMENT>0001181431-12-055507.txt : 20121025
<SEC-HEADER>0001181431-12-055507.hdr.sgml : 20121025
<ACCEPTANCE-DATETIME>20121025161719
ACCESSION NUMBER:		0001181431-12-055507
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20121023
FILED AS OF DATE:		20121025
DATE AS OF CHANGE:		20121025

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			POPE CHARLES L
		CENTRAL INDEX KEY:			0001136354

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32188
		FILM NUMBER:		121161661

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORAGENICS INC
		CENTRAL INDEX KEY:			0001174940
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				593410522
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		12085 RESEARCH DRIVE
		CITY:			ALACHUA
		STATE:			FL
		ZIP:			32615
		BUSINESS PHONE:		3864184018

	MAIL ADDRESS:	
		STREET 1:		12085 RESEARCH DRIVE
		CITY:			ALACHUA
		STATE:			FL
		ZIP:			32615
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>rrd358767.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2012-10-23</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001174940</issuerCik>
        <issuerName>ORAGENICS INC</issuerName>
        <issuerTradingSymbol>OGEN</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001136354</rptOwnerCik>
            <rptOwnerName>POPE CHARLES L</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>3000 BAYPORT DR.</rptOwnerStreet1>
            <rptOwnerStreet2>SUITE 685</rptOwnerStreet2>
            <rptOwnerCity>TAMPA</rptOwnerCity>
            <rptOwnerState>FL</rptOwnerState>
            <rptOwnerZipCode>33607</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2012-10-23</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>13081</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>49481</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Represents the portion of an aggregate performance award of 43,081 shares made in connection with, and as part of, the previously approved long term incentive compensation component of the director compensation program adopted by the Company and the award agreement with the reporting individual.  The award was originally made under the Company's Amended and Restated 2002 Stock Option and Incentive Plan (the &quot;Plan&quot;) and was based upon the determination that the specified performance goal related to the Company's securing financing had been achieved.  The initial award determination was made on August 6, 2012, pursuant to which 30,000 shares were awarded to the reporting person. The closing price of the Company's stock on such date was $ 2.75. (Continued in footnote 2)</footnote>
        <footnote id="F2">The balance of the performance award shares due of 13,081 was subject to shareholder approval of an amendment, restatement, and retitling of the Plan as well as an increase in the shares available for awards under the Plan, which occurred at the Company's annual meeting on October 23, 2012.  The closing price of the Company's stock on October 23, 2012 was $2.10.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Mark A. Catchur, as Attorney-in-Fact for Charles L. Pope</signatureName>
        <signatureDate>2012-10-25</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
